(Q51695915)

9 April 2018

title

Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia. (English)

1 reference

9 April 2018

0 references

3

1 reference

9 April 2018

author name string

Kuan-Po Huang

1

1 reference

9 April 2018

Andrew J Chase

2

1 reference

9 April 2018

Andrea Reiter

4

1 reference

9 April 2018

Tzu-Ying Li

5

1 reference

9 April 2018

Tso-Fu Wang

6

1 reference

9 April 2018

Sung-Chao Chu

7

1 reference

9 April 2018

Xuan-Yin Lu

8

1 reference

9 April 2018

Chi-Cheng Li

9

1 reference

9 April 2018

Ruey-Ho Kao

10

1 reference

9 April 2018

publication date

2 July 2008

1 reference

9 April 2018

International Journal of Hematology

published in

1 reference

9 April 2018

volume

88

1 reference

9 April 2018

issue

2

1 reference

9 April 2018

page(s)

197-201

1 reference

9 April 2018

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-008-0113-4

IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-008-0113-4

Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia

21 January 2018

1 reference

12 December 2020

Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy

1 reference

12 December 2020

Interferon-gamma-Induced MHC Class I Expression and Defects in Jak/Stat Signalling in Methylcholanthrene-Induced Sarcomas

1 reference

12 December 2020

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

12 December 2020

Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes

1 reference

12 December 2020

Differential effects of protein tyrosine kinase inhibitors on interferon-gamma-induction of major histocompatibility complex class II and intercellular adhesion molecule-1 expression in human corneal epithelial cells

1 reference

12 December 2020

Interferon-gamma-induced JAK2 and STAT1 signalling in a human salivary gland cell line

1 reference

12 December 2020

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

1 reference

12 December 2020

Immunophenotypic and cytogenetic changes in acute leukaemia at relapse

1 reference

12 December 2020

Molecular genetics of human leukemia

1 reference

12 December 2020

PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation

1 reference

12 December 2020

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

12 December 2020

Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia

1 reference

12 December 2020

Modification of histocompatibility antigen expression in cells expressing activated oncogenes: implications for tumour development.

1 reference

12 December 2020

Human major histocompatibility complex contains several leukemia susceptibility genes

1 reference

12 December 2020

Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases

1 reference

12 December 2020

Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case

1 reference

12 December 2020

A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma

1 reference

12 December 2020

Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia

1 reference

12 December 2020

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

12 December 2020

Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope

1 reference

12 December 2020

The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene

1 reference

12 December 2020

Clinical significance of cytogenetics in acute myeloid leukemia

1 reference

12 December 2020

10.1007/S12185-008-0113-4

Identifiers

DOI

1 reference

9 April 2018

1 reference

9 April 2018